search
Back to results

Transforaminal Epidural Injection in Acute Sciatica (TEIAS)

Primary Purpose

Sciatica, Sciatica Due to Intervertebral Disc Disorder, Sciatic Radiculopathy

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Lidocaine
Methylprednisolone Acetate
Dexamethasone
Sponsored by
C.L.A.Vleggeert-Lankamp
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sciatica focused on measuring Sciatica, Acute sciatica, Transforaminal epidural injection, Leg pain, Lumbar spine, Back pain, Lumbar surgery, Herniated intervertebral lumbar disk, Cost-effectiveness

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosed with sciatica by GP
  • NRS leg pain of 6 or more on a 10-point NRS scale
  • Minimum duration of symptoms of 3 weeks and maximum duration of 8 weeks

Exclusion Criteria:

  • Age under 18 years
  • Condition preventing to receive transforaminal epidural injection
  • Severe scoliosis
  • Transforaminal epidural injection received in 6 months before randomization date
  • Surgery for sciatica at the same level
  • Surgery for sciatica at another level within one year before inclusion
  • Pregnancy

Sites / Locations

  • Spaarne GasthuisRecruiting
  • Spaarne GasthuisRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Transforaminal Epidural Injection

Oral pain medication

Arm Description

Transforaminal Epidural Injection containing 1,5 mL lidocaine 2% and 40mg methylprednisolone acetate for injections L3 or below Transforaminal Epidural Injection containing 1,5 mL lidocaine 1% and 10mg dexamethasone for injections above L3

Patients will receive oral pain medication according to general practitioner guidelines.

Outcomes

Primary Outcome Measures

Numerical Rating Scale (NRS) for leg pain
Pain intensity in the leg using the NRS. 0 is the minimal score indicating no pain, 10 is the maximum indicating the worst imaginable pain. Scale increases with increments of 1.

Secondary Outcome Measures

Numerical Rating Scale (NRS) for leg pain
Pain intensity in the leg using the NRS. 0 is the minimal score indicating no pain, 10 is the maximum indicating the worst imaginable pain. Scale increases with increments of 1.
Numerical Rating Scale (NRS) for back pain
Pain intensity in the back using the NRS. 0 is the minimal score indicating no pain, 10 is the maximum indicating the worst imaginable pain. Scale increases with increments of 1.
Oswestry Disability Index (ODI)
Assessment of functionality using the ODI. 0 is the minimal score indicating no disability, 50 is the maximum indicating the worst disability possible. This questionnaire is based on 10 questions with answers corresponding to values of 0-5 points.
EuroQoL Cost Utility (EQ-5D)
Assessment of cost utility using the EuroQoL EQ-5D analysis tool. The tool measures five dimensions: mobility, self-care, daily activities, pain/discomfort and anxiety/depression.
Quality of Life Visual Analogue Scale
Assessment of the utility by valuation of the patient's health state representing the patient's perspective. 0 is the minimal score indicating 'as bad as death', 100 is the maximum indicating 'perfect health'. Scale increases with increments of 1.
Likert scale
Perceived recovery by the patient using the Likert scale. This is a 7-point scoring scale that ranges from 'completely recovered' to 'worse than ever'.
Cost diary
Determination of medical expenses due to health care utilization (costs of medication, physiotherapy, treatment by a medical specialist), patient costs (mobility aid, nursing care, domestic help), and absenteeism from work (amount of hours of absenteeism, hourly wage).
Complications from treatment with transforaminal epidural injection (TEI)
The occurrence and incidence of complications caused by treatment with TEI will be reported.
Level and shape of disc herniation from MRI data
The lumbar intervertebral level and shape of the herniated disc will be described based on MRI data
Size of disc herniation from MRI data
The size of the herniated disc will be reported in millimetres based on MRI data
Pfirrmann scale for disc degeneration on MRI
Disc degeneration on MRI will be assessed using the Pfirrmann scale which distinguishes 5 degrees of disc degeneration. Grade 1 indicates a normal disc. Higher grades indicate a more severe degenerative state of the intervertebral disc.
Histology of disc material obtained during surgery
Identification of immunological cells, macrophages and bacteria in disk material obtained during discectomy using staining, cell culture and polymerase chain reaction techniques.
Modic scale for end plate changes on MRI
The degree of end plate changes on MRI will be assessed using the Modic scale which distinguishes 3 degrees of end plate changes. All three Modic degrees indicate a certain type of underlying pathology in the vertebra. When the vertebra is normal, Modic changes are absent.
Weishaupt scale for facet degeneration on MRI
The degree of facet degeneration on MRI will be assessed using the Weishaupt scale which distinguishes 4 degrees of facet degeneration. Grade 0 indicates normal facet joint space. Higher grades indicate a more severe degenerative state of the facet joint.

Full Information

First Posted
April 10, 2019
Last Updated
October 18, 2023
Sponsor
C.L.A.Vleggeert-Lankamp
Collaborators
Spaarne Gasthuis, Stichting Achmea Gezondheidszor, Posthumus Meyjes Fonds
search

1. Study Identification

Unique Protocol Identification Number
NCT03924791
Brief Title
Transforaminal Epidural Injection in Acute Sciatica
Acronym
TEIAS
Official Title
Transforaminal Epidural Injection in Acute Sciatica
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2019 (Actual)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
July 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
C.L.A.Vleggeert-Lankamp
Collaborators
Spaarne Gasthuis, Stichting Achmea Gezondheidszor, Posthumus Meyjes Fonds

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Patients suffering from sciatica are treated conservatively for the first 8 weeks due to the favourable prognosis. This period is preferably extended up to 14-16 weeks after which patients may opt for surgery. However, patients may experience severe discomfort due to pain in the leg which can lead to decreased physical activity and socio-economic problems. An adequate therapy to alleviate symptoms during this period of 'wait-and-see' is lacking. In this study, patients will be randomized to treatment with transforaminal epidural injections or standard oral pain medication.
Detailed Description
Sciatica is a condition of radicular pain in the leg and is usually caused by herniation of a lumbar intervertebral disc. The herniated disc compresses a lumbar nerve root that continues its route into the sciatic nerve. About 13% to 40% of all people will suffer from sciatica at least once during their lifetime. Sciatica can have severe socio-economic effects; patients are immobilised by the pain they experience and therefore cannot go to work or participate in social events. Most cases resolve spontaneously with conservative therapy using only standard analgesics and/or physiotherapy. In a large RCT it was demonstrated that outcome of conservative and surgical therapy was comparable after 26 weeks. With this knowledge the guidelines for surgical treatment of sciatica were adjusted and it is nowadays usual care to offer surgery only after at least 8 weeks of conservative care and preferably after 14-16 weeks of conservative care. This decision is made together with the patient in a process of Shared Decision making. Although this treatment regimen has been demonstrated to be efficacious and cost effective, the burden for a patient during these weeks of conservative care is usually high. The investigators seek to find a type of conservative care to reduce the discomfort due to the pain and to enable the patient to remain physically active. Not only will this add to the quality of life of the patient, but it will also prevent the patient from taking a sick-leave. In this study, patients will be randomized to either treatment with transforaminal epidural injections or to standard care consisting of oral pain medication.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sciatica, Sciatica Due to Intervertebral Disc Disorder, Sciatic Radiculopathy
Keywords
Sciatica, Acute sciatica, Transforaminal epidural injection, Leg pain, Lumbar spine, Back pain, Lumbar surgery, Herniated intervertebral lumbar disk, Cost-effectiveness

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomized to either treatment with transforaminal epidural injection or standard oral pain medication.
Masking
None (Open Label)
Masking Description
Since masking is not possible for treatment with injections and oral pain medication, this is an open-label study. Outcomes are assessed by patients through online questionnaires and therefore the outcome assessor is not masked as well.
Allocation
Randomized
Enrollment
142 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Transforaminal Epidural Injection
Arm Type
Experimental
Arm Description
Transforaminal Epidural Injection containing 1,5 mL lidocaine 2% and 40mg methylprednisolone acetate for injections L3 or below Transforaminal Epidural Injection containing 1,5 mL lidocaine 1% and 10mg dexamethasone for injections above L3
Arm Title
Oral pain medication
Arm Type
No Intervention
Arm Description
Patients will receive oral pain medication according to general practitioner guidelines.
Intervention Type
Drug
Intervention Name(s)
Lidocaine
Intervention Description
In combination with dexamethasone or methylprednisolone acetate
Intervention Type
Drug
Intervention Name(s)
Methylprednisolone Acetate
Other Intervention Name(s)
Depo-Medrol
Intervention Description
In combination with lidocaine
Intervention Type
Drug
Intervention Name(s)
Dexamethasone
Intervention Description
In combination with lidocaine
Primary Outcome Measure Information:
Title
Numerical Rating Scale (NRS) for leg pain
Description
Pain intensity in the leg using the NRS. 0 is the minimal score indicating no pain, 10 is the maximum indicating the worst imaginable pain. Scale increases with increments of 1.
Time Frame
2 weeks after randomization
Secondary Outcome Measure Information:
Title
Numerical Rating Scale (NRS) for leg pain
Description
Pain intensity in the leg using the NRS. 0 is the minimal score indicating no pain, 10 is the maximum indicating the worst imaginable pain. Scale increases with increments of 1.
Time Frame
Baseline, 1, 4, 10 and 21 weeks after randomization
Title
Numerical Rating Scale (NRS) for back pain
Description
Pain intensity in the back using the NRS. 0 is the minimal score indicating no pain, 10 is the maximum indicating the worst imaginable pain. Scale increases with increments of 1.
Time Frame
Baseline, 1, 2, 4, 10 and 21 weeks after randomization
Title
Oswestry Disability Index (ODI)
Description
Assessment of functionality using the ODI. 0 is the minimal score indicating no disability, 50 is the maximum indicating the worst disability possible. This questionnaire is based on 10 questions with answers corresponding to values of 0-5 points.
Time Frame
Baseline, 1, 2, 4, 10 and 21 weeks after randomization
Title
EuroQoL Cost Utility (EQ-5D)
Description
Assessment of cost utility using the EuroQoL EQ-5D analysis tool. The tool measures five dimensions: mobility, self-care, daily activities, pain/discomfort and anxiety/depression.
Time Frame
Baseline, 2, 10 and 21 weeks after randomization
Title
Quality of Life Visual Analogue Scale
Description
Assessment of the utility by valuation of the patient's health state representing the patient's perspective. 0 is the minimal score indicating 'as bad as death', 100 is the maximum indicating 'perfect health'. Scale increases with increments of 1.
Time Frame
Baseline, 2, 10 and 21 weeks after randomization
Title
Likert scale
Description
Perceived recovery by the patient using the Likert scale. This is a 7-point scoring scale that ranges from 'completely recovered' to 'worse than ever'.
Time Frame
Baseline, 1, 2, 4, 10 and 21 weeks after randomization
Title
Cost diary
Description
Determination of medical expenses due to health care utilization (costs of medication, physiotherapy, treatment by a medical specialist), patient costs (mobility aid, nursing care, domestic help), and absenteeism from work (amount of hours of absenteeism, hourly wage).
Time Frame
10 and 21 weeks after randomization
Title
Complications from treatment with transforaminal epidural injection (TEI)
Description
The occurrence and incidence of complications caused by treatment with TEI will be reported.
Time Frame
Throughout the follow-up of 21 weeks
Title
Level and shape of disc herniation from MRI data
Description
The lumbar intervertebral level and shape of the herniated disc will be described based on MRI data
Time Frame
21 weeks after randomization
Title
Size of disc herniation from MRI data
Description
The size of the herniated disc will be reported in millimetres based on MRI data
Time Frame
21 weeks after randomization
Title
Pfirrmann scale for disc degeneration on MRI
Description
Disc degeneration on MRI will be assessed using the Pfirrmann scale which distinguishes 5 degrees of disc degeneration. Grade 1 indicates a normal disc. Higher grades indicate a more severe degenerative state of the intervertebral disc.
Time Frame
21 weeks after randomization
Title
Histology of disc material obtained during surgery
Description
Identification of immunological cells, macrophages and bacteria in disk material obtained during discectomy using staining, cell culture and polymerase chain reaction techniques.
Time Frame
21 weeks after randomization
Title
Modic scale for end plate changes on MRI
Description
The degree of end plate changes on MRI will be assessed using the Modic scale which distinguishes 3 degrees of end plate changes. All three Modic degrees indicate a certain type of underlying pathology in the vertebra. When the vertebra is normal, Modic changes are absent.
Time Frame
21 weeks after randomization
Title
Weishaupt scale for facet degeneration on MRI
Description
The degree of facet degeneration on MRI will be assessed using the Weishaupt scale which distinguishes 4 degrees of facet degeneration. Grade 0 indicates normal facet joint space. Higher grades indicate a more severe degenerative state of the facet joint.
Time Frame
21 weeks after randomization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosed with sciatica by GP NRS leg pain of 6 or more on a 10-point NRS scale Minimum duration of symptoms of 3 weeks and maximum duration of 8 weeks Exclusion Criteria: Age under 18 years Condition preventing to receive transforaminal epidural injection Severe scoliosis Transforaminal epidural injection received in 6 months before randomization date Surgery for sciatica at the same level Surgery for sciatica at another level within one year before inclusion Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Carmen LA Vleggeert-Lankamp, MD Msc Ph.D
Phone
+31715262109
Email
cvleggeert@lumc.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Eduard JA Verheijen, Bsc
Phone
+31715262109
Email
e.j.a.verheijen@lumc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carmen LA Vleggeert-Lankamp, MD Msc Ph.D
Organizational Affiliation
Leiden University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Spaarne Gasthuis
City
Haarlem
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carmen Vleggeert-Lankamp, M.D. Ph.D
Facility Name
Spaarne Gasthuis
City
Hoofddorp
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carmen Vleggeert-Lankamp, M.D. Ph.D

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
17538084
Citation
Peul WC, van Houwelingen HC, van den Hout WB, Brand R, Eekhof JA, Tans JT, Thomeer RT, Koes BW; Leiden-The Hague Spine Intervention Prognostic Study Group. Surgery versus prolonged conservative treatment for sciatica. N Engl J Med. 2007 May 31;356(22):2245-56. doi: 10.1056/NEJMoa064039.
Results Reference
background
PubMed Identifier
24710328
Citation
Hofstede SN, van Bodegom-Vos L, Wentink MM, Vleggeert-Lankamp CL, Vliet Vlieland TP, Marang-van de Mheen PJ; DISC study group. Most important factors for the implementation of shared decision making in sciatica care: ranking among professionals and patients. PLoS One. 2014 Apr 7;9(4):e94176. doi: 10.1371/journal.pone.0094176. eCollection 2014.
Results Reference
background
PubMed Identifier
28838872
Citation
Joswig H, Neff A, Ruppert C, Hildebrandt G, Stienen MN. The Value of Short-Term Pain Relief in Predicting the Long-Term Outcome of Lumbar Transforaminal Epidural Steroid Injections. World Neurosurg. 2017 Nov;107:764-771. doi: 10.1016/j.wneu.2017.08.055. Epub 2017 Aug 23.
Results Reference
background
PubMed Identifier
25448243
Citation
Spijker-Huiges A, Vermeulen K, Winters JC, van Wijhe M, van der Meer K. Epidural steroids for lumbosacral radicular syndrome compared to usual care: quality of life and cost utility in general practice. Arch Phys Med Rehabil. 2015 Mar;96(3):381-7. doi: 10.1016/j.apmr.2014.10.017. Epub 2014 Nov 8.
Results Reference
background
PubMed Identifier
1826546
Citation
Kuslich SD, Ulstrom CL, Michael CJ. The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop Clin North Am. 1991 Apr;22(2):181-7.
Results Reference
background
PubMed Identifier
8720407
Citation
Takahashi H, Suguro T, Okazima Y, Motegi M, Okada Y, Kakiuchi T. Inflammatory cytokines in the herniated disc of the lumbar spine. Spine (Phila Pa 1976). 1996 Jan 15;21(2):218-24. doi: 10.1097/00007632-199601150-00011.
Results Reference
background
PubMed Identifier
23874616
Citation
El Barzouhi A, Vleggeert-Lankamp CL, Lycklama A Nijeholt GJ, Van der Kallen BF, van den Hout WB, Verwoerd AJ, Koes BW, Peul WC; Leiden-The Hague Spine Intervention Prognostic Study Group. Magnetic resonance imaging interpretation in patients with sciatica who are potential candidates for lumbar disc surgery. PLoS One. 2013 Jul 10;8(7):e68411. doi: 10.1371/journal.pone.0068411. Print 2013.
Results Reference
background
PubMed Identifier
24325881
Citation
Verwoerd AJ, Peul WC, Willemsen SP, Koes BW, Vleggeert-Lankamp CL, el Barzouhi A, Luijsterburg PA, Verhagen AP. Diagnostic accuracy of history taking to assess lumbosacral nerve root compression. Spine J. 2014 Sep 1;14(9):2028-37. doi: 10.1016/j.spinee.2013.11.049. Epub 2013 Dec 8.
Results Reference
background
PubMed Identifier
24561397
Citation
el Barzouhi A, Vleggeert-Lankamp CL, Lycklama a Nijeholt GJ, Van der Kallen BF, van den Hout WB, Koes BW, Peul WC; Leiden-The Hague Spine Intervention Prognostic Study Group. Reliability of gadolinium-enhanced magnetic resonance imaging findings and their correlation with clinical outcome in patients with sciatica. Spine J. 2014 Nov 1;14(11):2598-607. doi: 10.1016/j.spinee.2014.02.028. Epub 2014 Feb 21.
Results Reference
background
PubMed Identifier
24637890
Citation
el Barzouhi A, Vleggeert-Lankamp CL, Lycklama a Nijeholt GJ, Van der Kallen BF, van den Hout WB, Koes BW, Peul WC; Leiden-The Hague Spine Intervention Prognostic Study Group. Influence of low back pain and prognostic value of MRI in sciatica patients in relation to back pain. PLoS One. 2014 Mar 17;9(3):e90800. doi: 10.1371/journal.pone.0090800. eCollection 2014.
Results Reference
background
PubMed Identifier
26842881
Citation
Verwoerd AJH, Mens J, El Barzouhi A, Peul WC, Koes BW, Verhagen AP. A diagnostic study in patients with sciatica establishing the importance of localization of worsening of pain during coughing, sneezing and straining to assess nerve root compression on MRI. Eur Spine J. 2016 May;25(5):1389-1392. doi: 10.1007/s00586-016-4393-8. Epub 2016 Feb 2.
Results Reference
background
PubMed Identifier
26871651
Citation
El Barzouhi A, Verwoerd AJ, Peul WC, Verhagen AP, Lycklama A Nijeholt GJ, Van der Kallen BF, Koes BW, Vleggeert-Lankamp CL; Leiden-The Hague Spine Intervention Prognostic Study Group. Prognostic value of magnetic resonance imaging findings in patients with sciatica. J Neurosurg Spine. 2016 Jun;24(6):978-85. doi: 10.3171/2015.10.SPINE15858. Epub 2016 Feb 12.
Results Reference
background
PubMed Identifier
25645576
Citation
Katz NP, Paillard FC, Ekman E. Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions. J Orthop Surg Res. 2015 Feb 3;10:24. doi: 10.1186/s13018-014-0144-x.
Results Reference
background
PubMed Identifier
27641258
Citation
Joswig H, Neff A, Ruppert C, Hildebrandt G, Stienen MN. The Value of Short-Term Pain Relief in Predicting the One-Month Outcome of Lumbar Transforaminal Epidural Steroid Injections. World Neurosurg. 2016 Dec;96:323-333. doi: 10.1016/j.wneu.2016.09.016. Epub 2016 Sep 15.
Results Reference
background
PubMed Identifier
31481010
Citation
Verheijen E, Munts AG, van Haagen O, de Vries D, Dekkers O, van den Hout W, Vleggeert-Lankamp C. Transforaminal epidural injection versus continued conservative care in acute sciatica (TEIAS trial): study protocol for a randomized controlled trial. BMC Neurol. 2019 Sep 3;19(1):216. doi: 10.1186/s12883-019-1445-9.
Results Reference
derived

Learn more about this trial

Transforaminal Epidural Injection in Acute Sciatica

We'll reach out to this number within 24 hrs